2022 ku post san antonio review | (neo)adjuvant therapy for triple negative breast cancer
Published 2 years ago • 682 plays • Length 23:20Download video MP4
Download video MP3
Similar videos
-
31:32
2022 ku post san antonio review | early-stage hormone breast cancer: optimizing systemic therapy
-
28:05
2022 ku post san antonio review | breast cancer risk assessment and reduction: what's new
-
30:10
2022 ku post san antonio review | metastatic her2 positive breast cancer: novel treatment approaches
-
24:34
2022 ku post san antonio review | updates in locoregional therapy
-
26:04
2022 ku post san antonio review | integration of biomarkers to inform treatment decisions
-
46:12
2022 ku post san antonio review | monday morning practice implications: q&a and case discussion 1
-
46:00
2022 ku post san antonio review | monday morning practice implications: q&a and case discussion 2
-
21:36
treatment planning for triple negative breast cancer | 2022 evolution conference
-
51:56
new & supporting data for optimizing therapy in her2 breast cancer | dr. kaklamani and dr. o’regan
-
22:57
2022 west oncology conference | breast cancers | metastatic
-
30:22
adjuvant therapy | 2023 ku breast cancer year in review conference
-
28:02
2022 west oncology conference | breast cancers | early-stage
-
1:17
neoadjuvant immunotherapy in tnbc and targeted lnd in breast cancer: 2023 best of breast conference
-
5:49
neoadjuvant treatment for triple-negative breast cancer
-
28:36
2021 mdons | breast cancer | updates from san antonio
-
36:33
breast cancer case-based panel discussion | 2022 midwest women's cancer conference
-
0:32
highlights in her2-low breast cancer at sabcs 2022
-
1:03
key takeaways from sabcs 2022